Michael Chiorean
@mchiorean4.bsky.social
IBD doc at Swedish Medical Center. Posts are my own
Included in non-aTNF biologics
December 10, 2024 at 1:51 PM
Included in non-aTNF biologics
I am part of that study 😊; that's why I was asking... It's a difficult endpoint but, I agree with you, technology is evolving
November 20, 2024 at 12:10 AM
I am part of that study 😊; that's why I was asking... It's a difficult endpoint but, I agree with you, technology is evolving
1. How do you measure it as a trial endpoint?
2. More importantly,,, so?... (what is the incremental impact on disease/patient outcomes?)
2. More importantly,,, so?... (what is the incremental impact on disease/patient outcomes?)
November 17, 2024 at 1:57 AM
1. How do you measure it as a trial endpoint?
2. More importantly,,, so?... (what is the incremental impact on disease/patient outcomes?)
2. More importantly,,, so?... (what is the incremental impact on disease/patient outcomes?)